Authors

• Özgür Eşi̇m (ORCID: https://orcid.org/0000-0002-6402-156X)
• Ayhan Savaşer (ORCID: https://orcid.org/0000-0001-8342-2919)
• Yalçın Özkan (ORCID: https://orcid.org/0000-0001-5163-6867)
• Esen Bellur Atıcı (ORCID: https://orcid.org/0000-0002-4093-441X)
• Meral Sarper (ORCID: https://orcid.org/0000-0002-9741-0641)
• Nurgül K. Bakırhan (ORCID: https://orcid.org/0000-0001-5469-9142)
• Cansel Köse Özkan (ORCID: https://orcid.org/0000-0002-4340-7279)
• Gizem Rüya Topal (ORCID: https://orcid.org/0000-0002-7715-6383)

Institutions

• Gebze Technical University (TR)
• University of Health Science (KH)
• Technology Holding (United States) (US)
• Sağlık Bilimleri Üniversitesi (TR)
• University of Health Sciences Antigua (AG)

Publication Details

Journal

Therapeutic Delivery

Published

2025-10-03

DOI

https://doi.org/10.1080/20415990.2025.2580275

Primary Topic

PARP inhibition in cancer therapy

Type

article

Field-Weighted Citation Impact

0.00